We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Lemierre's Syndrome Bacteria Are Responsible for Many Cases of Sore Throat Among Adolescents in the US

By LabMedica International staff writers
Posted on 23 Feb 2015
A recent study conducted at a student health clinic in the United States found that more cases of severe sore throat (pharyngitis) among young adults were caused by the bacterium Fusobacterium necrophorum than by hemolytic streptococci or by Mycoplasma pneumoniae.

The anaerobic bacterium F. More...
necrophorum was shown in European studies to account for about 10% of sore throats and was the primary cause of Lemierre's syndrome.

Lemierre's syndrome develops most often after a sore throat caused by some bacterium of the Streptococcus genus has created a peritonsillar abscess, a pocket filled with pus and bacteria near the tonsils. Deep in the abscess, anaerobic bacteria like F. necrophorum can flourish. The bacteria penetrate from the abscess into the neighboring jugular vein in the neck and there they cause an infected clot to form, from which bacteria are seeded throughout the body by the bloodstream. Bits of the infected clot break off and travel to the lungs as emboli where they block branches of the pulmonary artery bringing deoxygenated blood from the heart to the lungs. This causes shortness of breath, chest pain, and severe pneumonia. The syndrome affects mostly adolescents and young adults and is seen rarely in pre-adolescents. It often causes long, complex hospitalizations requiring intensive care, and although the organism is usually sensitive to penicillin and other antibiotics, about 6% of those contracting Lemierre’s syndrome die.

As there is little available data regarding F. necrophorum infection in the US, investigators at the University of Alabama (Birmingham, USA) used an in-house PCR assay to identify four different pathogenic microorganisms in throat swabs from 312 students aged 15 to 30 years presenting to a student health clinic with an acute sore throat and 180 asymptomatic students.

Results revealed that F. necrophorum was detected in 20.5% of patients and 9.4% of asymptomatic students. Group A beta-hemolytic Streptococcus was detected in 10.3% of patients and 1.1% of asymptomatic students. Group C/G beta-hemolytic Streptococcus was detected in 9.0% of patients and 3.9% of asymptomatic students. Mycoplasma pneumoniae was detected in 1.9% of patients and none of the asymptomatic students.

“This is the first study in the United States that shows that F. necrophorum causes a significant number of cases of pharyngitis in this young adult population,” said first author Dr. Robert M. Centor, professor of general internal medicine at the University of Alabama. “It is also the first to show that F. necrophorum pharyngitis and Streptococcus pharyngitis share similar clinical signs. This study bolsters our understanding that this condition is common in the US and very closely resembles strep throat.”

“It is not just about strep throat in this 15–30 age group,” said Dr. Centor. “Physicians have to consider F. necrophorum, which in our study caused more sore throats than strep. And, F. necrophorum is itself associated with a potentially devastating complication, which while rare, is a more common side effect that acute rheumatic fever. This is the first step in a series of studies that need to be done to define the prevalence and extent of F. necrophorum and how it presents clinically. A very important next step is to develop a practical and affordable point-of-care test for F. necrophorum.

The study was published in the February 17, 2015, online edition of the journal Annals of Internal Medicine.

Related Links:
University of Alabama



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Rapid Flu Test
Influenza A&B Rapid Test Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.